Funding, projects and partnerships
We form strategic partnerships to advance promising research related to our focus areas.
We apply our disease knowledge, translational expertise, cutting-edge science, networks and funding to progress projects. If you’re interested in partnering with us, please get in touch.
Find details of our existing work and open funding calls below.
Projects
Featured projects
-
Rare disease, Neurodegeneration
Elpida Therapeutics: Accelerating gene therapies for ultra‑rare neurodegenerative diseases
-
Our science
Our Future Health: Accelerating health research using clinical data
-
Childhood cancer
C-Further Consortium: advancing innovative cancer therapies for children and young people
-
Global health, Antimicrobial resistance
PACE: A £30 million collaborative initiative to tackle antimicrobial resistance
-
Chronic & rare respiratory
Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis project page
All projects
-
MND & rare dementias
CognoMND: Improving access to cognitive screening in motor neuron disease
-
MND & rare dementias
MinderCare: An NHS service helping people with dementia live independently for longer
-
MND & rare dementias
Neuropeutics Inc: A partnership to advance treatment for MND/ALS
-
MND & rare dementias
ALS TDI: Advancing ALS/MND prognosis, monitoring, and drug development
-
MND & rare dementias
MND STaR: Validating therapeutic targets for motor neuron disease with King’s College London
-
MND & rare dementias, Neurodegeneration
NEURii: Transforming care for people living with dementia throughUK-based collaboration
-
MND & rare dementias, Neurodegeneration
UKDRI: A £30 million partnership for the development of new dementia treatments
-
MND & rare dementias
Our work with the MND Community